The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
You are here Home Guidance and resources Sponsors Nexo Pharmaceuticals Pty Ltd Regulatory activities for this sponsor. Listen Print Share Loading... Type Designation or determination (1) Designation or determination (1) Prescription medicine evaluation (1) Prescription medicine evaluation (1) Date 2024 (1) 2024 (1) 2023 (1) 2023 (1) Search Sponsor content2 result(s) found, displaying 1 to 2 NexoBrid Nexo Pharmaceuticals Pty Ltd Jul-2024 Prescription medicine evaluation Active ingredient: anacaulase-bcdb. Notice for anacaulase-bcdb (Nexo Pharmaceuticals Pty Ltd) 28 August 2023 Designation or determination Orphan drug
NexoBrid Nexo Pharmaceuticals Pty Ltd Jul-2024 Prescription medicine evaluation Active ingredient: anacaulase-bcdb.
Notice for anacaulase-bcdb (Nexo Pharmaceuticals Pty Ltd) 28 August 2023 Designation or determination Orphan drug